Quantcast

Latest Intensive insulinotherapy Stories

2009-06-06 10:00:00

Latest data on ultra rapid acting insulin presented at the American Diabetes Association's 69th Scientific Sessions NEW ORLEANS, June 6 /PRNewswire-FirstCall/ -- The findings of two 52-week studies show that the investigational ultra rapid acting insulin AFRESA(R) (insulin human [rDNA origin]) Inhalation Powder combined with basal insulin is comparable to standard of care therapies in controlling post-meal blood sugar levels, and also results in significantly less weight gain and risk of...

2009-05-08 14:00:00

JACKSONVILLE, Fla. and ALEXANDRIA, Va., May 8 /PRNewswire-USNewswire/ -- New recommendations released today by a consensus group of the American Association of Clinical Endocrinologists (AACE) and the American Diabetes Association (ADA) are calling for major changes in the way health care professionals treat hospitalized patients with high blood glucose (sugar) levels. The authors recommend revised glucose targets of 140-180 mg/dL in the ICU setting, and between 100-180 mg/dL for most...

2009-03-24 09:42:09

Intensive insulin therapy significantly increases the risk of hypoglycemia in critically ill patients, found a new study in CMAJ (http://www.cmaj.ca/press/cmaj.090206.pdf).Intensive insulin therapy is used in many intensive care units around the world as a means to tightly regulate blood sugar. Although labour intensive, it has been recommended as a standard of care for critically ill patients by many organizations including the American Diabetes Association and the American Association of...

2008-11-07 00:00:22

Using an insulin pump to manage diabetes is assumed to be more convenient than daily injections, but U.S. researchers are checking quality of life. Dr. Max Stachura and an interdisciplinary Medical College of Georgia research team will measure that impact by studying more than 300 diabetics and their caregivers over the next two years. "Insulin pump technology is touted to improve flexibility in patients' lives," Stachura said in a statement. "Pumps get them away from multiple daily...

2008-10-30 09:00:00

WORCESTER, Mass., Oct. 30, 2008 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (http://www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today commented on the consensus algorithm for Type 2 diabetes treatment issued by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) published online on October 22, 2008 (Diabetes Care, volume 31, number 12, December 2008). A...

2008-09-17 15:00:37

AUSTIN, Texas, Sept. 17 /PRNewswire/ -- In a clinical trial comparing the i-port(R) (a small, disposable injection port about the size of a quarter) with standard injections in people with type 1 and type 2 diabetes, participants' differences in glycosylated albumin was not significantly different. The new data appeared in an article published in the current issue (Summer, 2008) of Diabetes Spectrum, a peer-reviewed journal of the American Diabetes Association. Glycosylated albumin is a...

2008-09-17 12:00:36

Generex Biotechnology has reached the enrollment milestone of more than 200 subjects in the company's pivotal Phase III clinical trial of Generex Oral-lyn, its proprietary prandial oral insulin spray product. The Phase III study will involve up to 750 subjects with Type-1 diabetes mellitus. There are 74 sites in the US, Canada, Bulgaria, Poland, Romania, Russia and Ukraine actively screening and enrolling subjects. The objective of this long-term study is to compare the efficacy of...

2008-07-09 06:00:38

Generex Biotechnology has initiated dosing of over one hundred patients in the company's pivotal Phase III clinical trial of Generex Oral-lyn, its flagship proprietary oral insulin spray product. The Phase III study will involve up to 750 patients with Type-1 Diabetes Mellitus centers in the US, Canada, Russia, and Eastern Europe. Dosing of patients is now underway at 31 clinical trial sites in the US, Canada, Russia, and Ukraine. The objective of the six-month study is to compare the...

2006-06-12 17:51:35

By Maggie Fox, Health and Science Correspondent WASHINGTON (Reuters) - A new device that monitors blood sugar constantly and lets the patient pump insulin right away if needed might greatly simplify life for people with diabetes, experts told a meeting on Monday. The Medtronic Inc. device combines an insulin pump and a continuous blood-monitoring system. It sounds an alarm if blood sugar goes out of safe ranges. Patients are clamoring to test and use the device, researchers for the...

2005-07-14 12:23:15

By David Douglas NEW YORK (Reuters Health) - Inhaled insulin offers patients with type 1 diabetes the potential of avoiding pre-meal injections -- without any loss of diabetes control, a study shows. "This can improve their quality of life, " Dr. Jay S. Skyler, of the University of Miami, who led the study, told Reuters Health. In the study, taking an inhaled form of insulin before meals with insulin injections at other times during the day provided blood sugar control comparable to that...


Word of the Day
Cthulhu
  • A gigantic fictional humanoid alien god being described with a head resembling an octopus and dragon wings and claws, around whom an insane cult developed.
  • Pertaining to the mythos of Cthulhu and additional otherworldly beings created by H. P. Lovecraft or inspired by his writings and imitators.
This word was invented in 1926 by H.P. Lovecraft for his short story, 'The Call of Cthulhu.' 'Cthulhu' may be based on the word 'chthonic,' which in Greek mythology refers to the underworld.
Related